BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gilchrist A. Chemokines and Bone. Handb Exp Pharmacol 2020;262:231-58. [PMID: 32661663 DOI: 10.1007/164_2020_349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Gilchrist A, Echeverria SL. Targeting Chemokine Receptor CCR1 as a Potential Therapeutic Approach for Multiple Myeloma. Front Endocrinol (Lausanne) 2022;13:846310. [PMID: 35399952 DOI: 10.3389/fendo.2022.846310] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Geneva-popova MG, Popova-belova SD, Gardzheva PN, Kraev KI. A Study of IFN-α-Induced Chemokines CCL2, CXCL10 and CCL19 in Patients with Systemic Lupus Erythematosu. Life 2022;12:251. [DOI: 10.3390/life12020251] [Reference Citation Analysis]
3 Yan Y, Su J, Zhang Z. The CXCL12/CXCR4/ACKR3 Response Axis in Chronic Neurodegenerative Disorders of the Central Nervous System: Therapeutic Target and Biomarker. Cell Mol Neurobiol 2021. [PMID: 34117967 DOI: 10.1007/s10571-021-01115-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]